JP2022523554A5 - - Google Patents
Info
- Publication number
- JP2022523554A5 JP2022523554A5 JP2021552600A JP2021552600A JP2022523554A5 JP 2022523554 A5 JP2022523554 A5 JP 2022523554A5 JP 2021552600 A JP2021552600 A JP 2021552600A JP 2021552600 A JP2021552600 A JP 2021552600A JP 2022523554 A5 JP2022523554 A5 JP 2022523554A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- eso
- tcr
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163997A JP2025000725A (ja) | 2019-03-04 | 2024-09-20 | Ｔ細胞受容体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813642P | 2019-03-04 | 2019-03-04 | |
| US62/813,642 | 2019-03-04 | ||
| PCT/IB2020/051808 WO2020178739A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163997A Division JP2025000725A (ja) | 2019-03-04 | 2024-09-20 | Ｔ細胞受容体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523554A JP2022523554A (ja) | 2022-04-25 |
| JP2022523554A5 true JP2022523554A5 (enExample) | 2023-03-13 |
| JP7561133B2 JP7561133B2 (ja) | 2024-10-03 |
Family
ID=72337709
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552600A Active JP7561133B2 (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
| JP2024163997A Pending JP2025000725A (ja) | 2019-03-04 | 2024-09-20 | Ｔ細胞受容体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163997A Pending JP2025000725A (ja) | 2019-03-04 | 2024-09-20 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220152104A1 (enExample) |
| EP (1) | EP3935174A4 (enExample) |
| JP (2) | JP7561133B2 (enExample) |
| KR (1) | KR20210149050A (enExample) |
| CN (1) | CN113906141B (enExample) |
| AU (1) | AU2020231927A1 (enExample) |
| BR (1) | BR112021017464A2 (enExample) |
| CA (1) | CA3132238A1 (enExample) |
| IL (1) | IL286037A (enExample) |
| MX (1) | MX2021010543A (enExample) |
| SG (1) | SG11202109589VA (enExample) |
| TW (1) | TWI872051B (enExample) |
| WO (1) | WO2020178739A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| WO2020178739A1 (en) * | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
| CA3233809A1 (en) * | 2021-10-06 | 2023-04-13 | University Health Network | Modified immune cells and methods of use thereof |
| AU2024269870A1 (en) * | 2023-05-05 | 2025-11-20 | Board Of Regents, The University Of Texas System | Multi-receptor natural killer cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101363928B1 (ko) * | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| HRP20171164T1 (hr) * | 2010-09-20 | 2017-10-20 | Biontech Cell & Gene Therapies Gmbh | Antigen-specifični t stanični receptori i t stanični epitopi |
| EP3604271A1 (en) * | 2013-06-28 | 2020-02-05 | Auckland Uniservices Limited | Peptides for amino acid and peptide conjugates and conjugation process |
| KR101503341B1 (ko) * | 2014-03-12 | 2015-03-18 | 국립암센터 | 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법 |
| WO2017076308A1 (zh) * | 2015-11-04 | 2017-05-11 | 广州市香雪制药股份有限公司 | 识别ny-eso-1抗原短肽的tcr |
| DK3399985T3 (da) * | 2016-01-06 | 2022-03-21 | Health Research Inc | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer |
| WO2020178739A1 (en) * | 2019-03-04 | 2020-09-10 | University Health Network | T cell receptors and methods of use thereof |
-
2020
- 2020-03-03 WO PCT/IB2020/051808 patent/WO2020178739A1/en not_active Ceased
- 2020-03-03 CN CN202080028561.6A patent/CN113906141B/zh active Active
- 2020-03-03 US US17/436,931 patent/US20220152104A1/en active Pending
- 2020-03-03 BR BR112021017464A patent/BR112021017464A2/pt unknown
- 2020-03-03 JP JP2021552600A patent/JP7561133B2/ja active Active
- 2020-03-03 KR KR1020217031570A patent/KR20210149050A/ko active Pending
- 2020-03-03 AU AU2020231927A patent/AU2020231927A1/en active Pending
- 2020-03-03 CA CA3132238A patent/CA3132238A1/en active Pending
- 2020-03-03 MX MX2021010543A patent/MX2021010543A/es unknown
- 2020-03-03 EP EP20765783.4A patent/EP3935174A4/en active Pending
- 2020-03-03 SG SG11202109589V patent/SG11202109589VA/en unknown
- 2020-03-04 TW TW109107111A patent/TWI872051B/zh active
-
2021
- 2021-09-01 IL IL286037A patent/IL286037A/en unknown
-
2024
- 2024-09-20 JP JP2024163997A patent/JP2025000725A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022524993A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| JP2022523971A5 (enExample) | ||
| JP2022524992A5 (enExample) | ||
| Baxevanis et al. | Cancer immunotherapy | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| EP2446897A1 (en) | Anti-KIR combination treatments and methods | |
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| AU2025203036A1 (en) | NKT-cell subset for in vivo persistence and therapeutic activity and propagation of same | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| AU2018219862B2 (en) | Maximizing T-cell memory and compositions and methods therefor | |
| JP2022543059A5 (enExample) | ||
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| JP2020533962A5 (enExample) | ||
| AU2020231694A1 (en) | T cell receptors and methods of use thereof | |
| JP2023542528A5 (enExample) | ||
| JP2022543060A5 (enExample) | ||
| JP2022543058A5 (enExample) | ||
| KR20250158012A (ko) | 키메라 항원 수용체 | |
| CN114502577A (zh) | 结合病毒抗原的nk接合器化合物和使用方法 | |
| Chow et al. | Cellular immunotherapy for high-grade glioma |